LTK Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of LTK Antibodies for research focused on understanding LTK, a member of the receptor tyrosine kinase family. LTK Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LTK plays a crucial role in cellular signaling pathways that regulate cell growth, differentiation, and survival. Research has shown LTK's significant involvement in neurogenesis and potential implications in various cancers. Understanding LTK function and regulation can provide valuable insights into therapeutic strategies for diseases associated with its dysregulation. Ongoing studies continue to reveal new aspects of LTK's biological significance and potential therapeutic applications. Current research emphasizes LTK's role in cellular development and disease progression. Investigating LTK's molecular mechanisms and signaling pathways remains a priority in multiple fields of study. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of LTK and its impact on human health.